***Live: Tuesday, December 1, 2020 at 10am EST| 9am CST| 3pm GMT| 4pm CET***Formulators face special challenges with developing parenteral drugs to achieve the needed stability, efficacy and sterility. Learn how high purity excipients can be used to address formulation issues, while complying with regulatory requirements.*** On demand available after final airing until Dec. 1, 2021.***
Register Free: https://www.pharmtech.com/pt_w/high_purity_excipients
Event Overview: Demand for parenteral formulations is growing as the overall drug market expands and new therapies enter the pipeline. These drug forms require special formulation considerations related to chemical and physical stability, sterility, viscosity. Excipients play a crucial role in formulating a safe, effective drug.
In this webcast, experts will discuss key factors associated with formulating a parenteral drug including evaluating excipients to be used in sterilized drug products, understanding the chemical structure, evaluating grades of excipients, and more.
Important insights about the regulatory and quality aspects surrounding parenteral excipients such as elemental impurities, microbiological/endotoxin analytics, and compendial compliance, regulatory documentation will be shared.
The ways in which an excipient supplier can best support the drug product control strategy will be discussed.
Key Learning Objectives:
Speakers: Dr. Lindsay Johnson, Global Technical Marketing Manager- Solubilization Portfolio, BASF
Dr. Dorothee Kriha, Regulatory Manager – Pharma Solutions, BASF
Time and Date: Tuesday, December 1, 2020 at 10am EST| 9am CST| 3pm GMT| 4pm CET
On demand available after final airing until Dec. 1, 2021
Register free: https://www.pharmtech.com/pt_w/high_purity_excipients